medigraphic.com
ISSN 1561-3186 (Electronic)

2016, Number 1

<< Back Next >>

Rev Acta Médica 2016; 17 (1)

Poor nutrition and psychotic disorders brain

Marot CM

Language: Spanish
References: 33
Page:
PDF size: 72.79 Kb.


ABSTRACT

Delusions and hallucinations are the dimension "psychoticism" present in different diagnostic categories of mental disorders and behavioral systemized in the Tenth Revision of the International Classification of Diseases (ICD-10), including schizophrenia and other psychoses include related and depressive and manic episodes with psychotic symptoms. Knowledge of the neurobiological basis of psychotic symptoms can pose, from an interdisciplinary position, the criterion of poor nutrition as a member of cerebral disease state in these disorders. Inadequate nutrient bioavailability prevents effective functioning of brain cells or cell metabolism and nutrition. The membrane hypothesis suggests that psychotic disorders may present with phospholipid metabolism disorders level of cellular membranes by decreasing the polyunsaturated fatty acids of the omega-3 series at that level in the brain and other body tissues. Nutritional interventions is also recommended in the design of care at any level of patients with psychotic disorders by its chronic state of malnutrition and often cerebral, peripheral.


REFERENCES

  1. World Health Organization. The International Statistical Classification of Diseases and Health Related Problems. 10. Geneva: WHO; 1992.

  2. Mergenthaler P, Lindauer U, Dienel GA, Meisel A. Sugar for the brain: the role of glucose in physiological and pathological brain function. Trends Neurosci. 2013 Oct;36(10):587-97.

  3. Sublette ME, Galfalvy HC, Hibbeln J, Keilp J, Malone K, Oquendo M. Polyunsaturated Fatty Acid Associations with Dopaminergic Indices in Major Depressive Disorder. Int J Neuropsychopharmacol. 2014 Mar;17(3):383-91.

  4. Horrobin D, Iain A, Glen M, Vaddadi K. The membrana hypothesis of schizophrenia. Schizophrenia Research. 1994;13:105-207.

  5. Vaddadi K. Essential fatty acids and mental illness. Int Rev Psychiatry. 2006 Apr;18(2):81-4.

  6. McNamara RK, Strawn JR. Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice. Pharma Nutrition. 2013 Apr;1(2):41-9.

  7. Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, et al. Role of Omega-3 Fatty Acids in the Treatment of Depressive Disorders: A Comprehensive Meta-Analysis of Randomized Clinical Trials. PLoS ONE. 2014;9(5):e96905. doi:10.1371/journal.pone.0096905.

  8. Nasiff-Hadad A. Dislipoproteinemias. En: Manual de diagnóstico y tratamiento en especialidades clínicas. Colectivo de autores. La Habana: Ed. Polit.; 2002. p. 189-95.

  9. Prior PL, Fernandes-Galduróz JC. (N-3) Fatty Acids: Molecular Role and Clinical Uses in Psychiatric Disorders. Adv Nutr. 2012 May;3(3):257-65.

  10. Assies J, Mocking RJT, Lok A, Ruhé HG, Pouwer F, Schene AH. Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity. Acta Psychiatr Scand. 2014 Sep;130(3):163-80.

  11. De Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011 Feb; 10(1):52-77.

  12. De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the World Psychiatry. 2011 June;10(2):138-51.

  13. Leboyer M, Soreca I, Scott J, Frye M, Henry Ch, Tamouza R, et al. Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord. 2012 Dec 1;141(1):1-10.

  14. Kirkpatrick B, Miller B, Garcia-Rizo C, Fernández-Egea E. Schizophrenia: A Systemic Disorder. Clin Schizophr Relat Psychoses. 2014 Jul;8(2):73-9.

  15. Papanastasiou E. The prevalence and mechanisms of metabolic syndrome in schizophrenia: a review. Ther Adv Psychopharmacol. 2013 Feb;3(1):33-51.

  16. Meduna LJ. Oneirophrenia. The University of Illinois Press Urbana; 1950.

  17. Holden R, Money P. Schizophrenia is a diabetic brain state: a elucidation of impaired neurometabolism. Medical Hypotheses 1994;43:420-35.

  18. Newman J, Holden R. The cerebral diabetes, paradigm for unipolar depression. Medical Hypotheses. 1993;41:391-408.

  19. McDermott E, de Silva P. Impaired neuronal glucose uptake in pathogenesis of schizophrenia - can GLUT 1 and GLUT 3 deficits explain imaging, post-mortem and pharmacological findings? Med Hypotheses. 2005;65(6):1076-81.

  20. De Silva PN. Does the association with diabetes say more about schizophrenia and its treatment? -The GLUT hypothesis. Medical Hypotheses. 2011;77(4):529-31.

  21. Raphael TP, Parsons JP. Blood sugar studies in dementia praecox and manicdepressive insanity. Arch Neurol Psychiatry. 1921;5:687-709 .

  22. Langfeldt G. The insulin tolerance test in mental disorders. Acta Psychiatr Neurol Scand Suppl. 1952;80:189-99.

  23. González de Rivera JL. Aspectos endocrinos de las enfermedades mentales. Pesquis. 1980;4:94-7.

  24. Trouve BP. Semiología Psiquiátrica. España: Ed. Toray-Masson; 1975. p. 243.

  25. López Mato AM. Introducción a la Psiconeuroinmunoendocrinología. Cap. 60. En: Sadock BJ, Kaplan H. Tratado de Psiquiatría VI. 1997 (6ª ed.). Inter-Medica Editorial: Buenos Aires; p.1127-58.

  26. Bell L, Marot M, Cancio E. Posible estado de insulinorresistencia en pacientes esquizofrénicos. Revista Argentina de Psiquiatría Biológica. 1996;3(15):13-6.

  27. Baller J, McGinty E, Azrin S, Juliano-Bult D, Daumit G. Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence. BMC Psychiatry. 2015;15:55.

  28. de Hert M, Schreurs V, van Campfort D, van Winkel R. Metabolic syndrome in people with schizophrenia: a review. World Psychiatry. 2009 Feb;8(1):15-22.

  29. Manu P, Kane JM, Correll CU. Sudden deaths in psychiatric patients. J Clin Psychiatry. 2011 Jul;72(7):936-41. Epub 2011 May 3.

  30. Saiz-Ruiz J, Bobes García J, Vallejo Ruiloba J, Giner Ubago J, García-Portilla González MP. Grupo de Trabajo sobre la Salud Física del Paciente con Esquizofrenia. Consenso sobre la salud física del paciente con esquizofrenia de las Sociedades Españolas de Psiquiatría y de Psiquiatría Biológica. Actas Esp Psiquiatr. 2008;36:251- 64.

  31. Bobes García J, Saiz-Ruiz J, Bernardo-Arroyo M, Caballero-Martínez F, Gilaberte Asin I, Ciudad-Herrera A. Consenso delphi sobre la salud física del paciente con esquizofrenia: valoración por un panel de expertos de las recomendaciones de las Sociedades Españolas de Psiquiatría y de Psiquiatría Biológica. Actas Esp Psiquiatr. 2012;40(3):114-28.

  32. Sarris J, Logan AC, Akbaraly TN, Paul Amminger G, Balanzá-Martínez V, Freeman MP, et al. International Society for Nutritional Psychiatry Research consensus position statement: nutritional medicine in modern psychiatry. World Psychiatry. 2015 Oct;14(3):370-1.

  33. Logan A, Jacka F. Nutritional psychiatry research: an emerging discipline and its intersection with global urbanization, environmental challenges and the evolutionary mismatch. J Physiol Anthropol. 2014;33(1):22.




2020     |     www.medigraphic.com